Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Breast Cancer”

773 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 773 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT00383500
What this trial is testing

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

Who this might be right for
LymphedemaBreast Cancer
Stanford University 75
Not applicableStudy completedNCT04257474
What this trial is testing

Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 265
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Not applicableStudy completedNCT01314963
What this trial is testing

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

Who this might be right for
Multiple MyelomaBreast Cancer
Stanford University 50
Not applicableStudy completedNCT00667121
What this trial is testing

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Who this might be right for
Breast CancerDepressionHot Flashes+1 more
Mayo Clinic 88
Not applicableStudy completedNCT00923377
What this trial is testing

Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00291694
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 72
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Not applicableStudy completedNCT02831439
What this trial is testing

A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care

Who this might be right for
Breast Cancer
Medical College of Wisconsin 400,415
Testing effectiveness (Phase 2)Study completedNCT00004900
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hackensack Meridian Health
Not applicableStudy completedNCT00084669
What this trial is testing

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerHot FlashesSleep Disorders
Massachusetts General Hospital 119
Not applicableUnknownNCT05305937
What this trial is testing

Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors

Who this might be right for
Malignant Tumor of BreastBenign Breast LumpsHigh-Risk Breast Cancer
Meir Medical Center 70
Not applicableUnknownNCT04821609
What this trial is testing

Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema

Who this might be right for
Breast CancerPhysical ActivityLymphedema of Upper Arm
Pontificia Universidad Catolica de Chile 106
Testing effectiveness (Phase 2)WithdrawnNCT00022230
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT01069081
What this trial is testing

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasis, Neoplasm
Fudan University 94
Not applicableStudy completedNCT03859492
What this trial is testing

Screening CEDM in Intermediate and High-Risk Patient Populations

Who this might be right for
Breast Cancer
Mayo Clinic 461
Not applicableActive Not RecruitingNCT05939128
What this trial is testing

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA

Who this might be right for
Breast Cancer
AstraZeneca 625
Testing effectiveness (Phase 2)WithdrawnNCT02521077
What this trial is testing

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Who this might be right for
Fatigue
Midwestern Regional Medical Center
Early research (Phase 1)Study completedNCT01339650
What this trial is testing

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian
AbbVie (prior sponsor, Abbott) 93
Next Page